
### [NCIT:C4914](http://purl.obolibrary.org/obo/NCIT_C4914)
**Label:** Skin Carcinoma

**Subclasses:** [NCIT:C27255](http://purl.obolibrary.org/obo/NCIT_C27255) (Eccrine Carcinoma), [NCIT:C27533](http://purl.obolibrary.org/obo/NCIT_C27533) (Primary Cutaneous Mucinous Carcinoma), [NCIT:C7903](http://purl.obolibrary.org/obo/NCIT_C7903) (Recurrent Skin Carcinoma), [NCIT:C4114](http://purl.obolibrary.org/obo/NCIT_C4114) (Pilomatrical Carcinoma), [NCIT:C27254](http://purl.obolibrary.org/obo/NCIT_C27254) (Papillary Eccrine Carcinoma), [NCIT:C6811](http://purl.obolibrary.org/obo/NCIT_C6811) (Plantar Verrucous Skin Carcinoma), [NCIT:C134831](http://purl.obolibrary.org/obo/NCIT_C134831) (Eyelid Sebaceous Gland Carcinoma), [NCIT:C43340](http://purl.obolibrary.org/obo/NCIT_C43340) (Ocular Sebaceous Carcinoma), [NCIT:C5568](http://purl.obolibrary.org/obo/NCIT_C5568) (Skin Nodulo-Ulcerative Basal Cell Carcinoma), [NCIT:C4472](http://purl.obolibrary.org/obo/NCIT_C4472) (Mucoepidermoid Skin Carcinoma), [NCIT:C27539](http://purl.obolibrary.org/obo/NCIT_C27539) (Skin Infiltrating Basal Cell Carcinoma), [NCIT:C43341](http://purl.obolibrary.org/obo/NCIT_C43341) (Extraocular Cutaneous Sebaceous Carcinoma), [NCIT:C85897](http://purl.obolibrary.org/obo/NCIT_C85897) (Stage III Merkel Cell Carcinoma AJCC v7), [NCIT:C43344](http://purl.obolibrary.org/obo/NCIT_C43344) (Carcinoma ex Eccrine Spiradenoma), [NCIT:C43345](http://purl.obolibrary.org/obo/NCIT_C43345) (Ductal Eccrine Adenocarcinoma), [NCIT:C27535](http://purl.obolibrary.org/obo/NCIT_C27535) (Skin Adenoid Basal Cell Carcinoma), [NCIT:C43346](http://purl.obolibrary.org/obo/NCIT_C43346) (Ductal Eccrine Carcinoma with Spindle Cell Elements), [NCIT:C7581](http://purl.obolibrary.org/obo/NCIT_C7581) (Microcystic Adnexal Carcinoma), [NCIT:C43347](http://purl.obolibrary.org/obo/NCIT_C43347) (Ductal Eccrine Carcinoma with Squamous Metaplasia), [NCIT:C27537](http://purl.obolibrary.org/obo/NCIT_C27537) (Skin Cystic Basal Cell Carcinoma), [NCIT:C27536](http://purl.obolibrary.org/obo/NCIT_C27536) (Skin Clear Cell Basal Cell Carcinoma), [NCIT:C4471](http://purl.obolibrary.org/obo/NCIT_C4471) (Adenoid Cystic Skin Carcinoma), [NCIT:C5560](http://purl.obolibrary.org/obo/NCIT_C5560) (Eccrine Porocarcinoma), [NCIT:C6381](http://purl.obolibrary.org/obo/NCIT_C6381) (Vulvar Basal Cell Carcinoma), [NCIT:C85893](http://purl.obolibrary.org/obo/NCIT_C85893) (Stage II Merkel Cell Carcinoma AJCC v7), [NCIT:C6938](http://purl.obolibrary.org/obo/NCIT_C6938) (Sweat Gland Carcinoma), [NCIT:C8209](http://purl.obolibrary.org/obo/NCIT_C8209) (Stage IV Lip Basal Cell Carcinoma), [NCIT:C5616](http://purl.obolibrary.org/obo/NCIT_C5616) (Skin Nodular Solid Basal Cell Carcinoma), [NCIT:C5457](http://purl.obolibrary.org/obo/NCIT_C5457) (Invasive Apocrine Breast Carcinoma), [NCIT:C8205](http://purl.obolibrary.org/obo/NCIT_C8205) (Stage III Lip Basal Cell Carcinoma), [NCIT:C7476](http://purl.obolibrary.org/obo/NCIT_C7476) (Paget Disease of the Anal Margin), [NCIT:C85887](http://purl.obolibrary.org/obo/NCIT_C85887) (Stage 0 Merkel Cell Carcinoma AJCC v7), [NCIT:C8201](http://purl.obolibrary.org/obo/NCIT_C8201) (Stage II Lip Basal Cell Carcinoma), [NCIT:C85889](http://purl.obolibrary.org/obo/NCIT_C85889) (Stage I Merkel Cell Carcinoma AJCC v7), [NCIT:C7472](http://purl.obolibrary.org/obo/NCIT_C7472) (Anal Margin Carcinoma), [NCIT:C7473](http://purl.obolibrary.org/obo/NCIT_C7473) (Anal Margin Basal Cell Carcinoma), [NCIT:C5180](http://purl.obolibrary.org/obo/NCIT_C5180) (Malignant Breast Eccrine Spiradenoma), [NCIT:C2906](http://purl.obolibrary.org/obo/NCIT_C2906) (Skin Squamous Cell Carcinoma In Situ), [NCIT:C4459](http://purl.obolibrary.org/obo/NCIT_C4459) (Clear Cell Squamous Cell Skin Carcinoma), [NCIT:C3640](http://purl.obolibrary.org/obo/NCIT_C3640) (Stage 0 Skin Cancer), [NCIT:C8014](http://purl.obolibrary.org/obo/NCIT_C8014) (Lip Basal Cell Carcinoma), [NCIT:C136870](http://purl.obolibrary.org/obo/NCIT_C136870) (Merkel Cell Carcinoma by AJCC v8 Stage), [NCIT:C5140](http://purl.obolibrary.org/obo/NCIT_C5140) (Apocrine Breast Carcinoma In Situ), [NCIT:C5141](http://purl.obolibrary.org/obo/NCIT_C5141) (Apocrine Breast Carcinoma), [NCIT:C43326](http://purl.obolibrary.org/obo/NCIT_C43326) (Trichilemmocarcinoma), [NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma), [NCIT:C6082](http://purl.obolibrary.org/obo/NCIT_C6082) (External Ear Basal Cell Carcinoma), [NCIT:C6083](http://purl.obolibrary.org/obo/NCIT_C6083) (External Ear Squamous Cell Carcinoma), [NCIT:C128164](http://purl.obolibrary.org/obo/NCIT_C128164) (Vulvar Adenocarcinoma of Sweat Gland Type), [NCIT:C6925](http://purl.obolibrary.org/obo/NCIT_C6925) (Anal Margin Squamous Cell Carcinoma), [NCIT:C27543](http://purl.obolibrary.org/obo/NCIT_C27543) (Skin Basaloid Carcinoma), [NCIT:C4346](http://purl.obolibrary.org/obo/NCIT_C4346) (Skin Basal Cell Carcinoma with Sebaceous Differentiation), [NCIT:C3775](http://purl.obolibrary.org/obo/NCIT_C3775) (Adnexal Carcinoma), [NCIT:C9359](http://purl.obolibrary.org/obo/NCIT_C9359) (Skin Pigmented Basal Cell Carcinoma), [NCIT:C85900](http://purl.obolibrary.org/obo/NCIT_C85900) (Stage IV Merkel Cell Carcinoma AJCC v7), [NCIT:C9231](http://purl.obolibrary.org/obo/NCIT_C9231) (Merkel Cell Carcinoma), [NCIT:C136869](http://purl.obolibrary.org/obo/NCIT_C136869) (Merkel Cell Carcinoma by AJCC v7 Stage), [NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma), [NCIT:C40309](http://purl.obolibrary.org/obo/NCIT_C40309) (Vulvar Sebaceous Carcinoma), [NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma), [NCIT:C40307](http://purl.obolibrary.org/obo/NCIT_C40307) (Vulvar Clear Cell Hidradenocarcinoma), [NCIT:C40305](http://purl.obolibrary.org/obo/NCIT_C40305) (Vulvar Eccrine Adenocarcinoma), [NCIT:C8197](http://purl.obolibrary.org/obo/NCIT_C8197) (Stage I Lip Basal Cell Carcinoma), [NCIT:C62571](http://purl.obolibrary.org/obo/NCIT_C62571) (Bowen Disease of the Skin), [NCIT:C27182](http://purl.obolibrary.org/obo/NCIT_C27182) (Skin Morphea-Type (Sclerosing) Basal Cell Carcinoma), [NCIT:C38109](http://purl.obolibrary.org/obo/NCIT_C38109) (Skin Basal Cell Carcinoma with Adnexal Differentiation), [NCIT:C133255](http://purl.obolibrary.org/obo/NCIT_C133255) (Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8), [NCIT:C133256](http://purl.obolibrary.org/obo/NCIT_C133256) (Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8), [NCIT:C133253](http://purl.obolibrary.org/obo/NCIT_C133253) (Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage), [NCIT:C133259](http://purl.obolibrary.org/obo/NCIT_C133259) (Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8), [NCIT:C4169](http://purl.obolibrary.org/obo/NCIT_C4169) (Apocrine Carcinoma), [NCIT:C133257](http://purl.obolibrary.org/obo/NCIT_C133257) (Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8), [NCIT:C133258](http://purl.obolibrary.org/obo/NCIT_C133258) (Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8), [NCIT:C5893](http://purl.obolibrary.org/obo/NCIT_C5893) (Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7), [NCIT:C115440](http://purl.obolibrary.org/obo/NCIT_C115440) (Recurrent Merkel Cell Carcinoma), [NCIT:C133252](http://purl.obolibrary.org/obo/NCIT_C133252) (Cutaneous Squamous Cell Carcinoma of the Head and Neck), [NCIT:C5583](http://purl.obolibrary.org/obo/NCIT_C5583) (Stage III Skin Cancer), [NCIT:C5584](http://purl.obolibrary.org/obo/NCIT_C5584) (Stage IV Skin Cancer), [NCIT:C54250](http://purl.obolibrary.org/obo/NCIT_C54250) (Skin Adenosquamous Carcinoma), [NCIT:C8213](http://purl.obolibrary.org/obo/NCIT_C8213) (Recurrent Lip Basal Cell Carcinoma), [NCIT:C3682](http://purl.obolibrary.org/obo/NCIT_C3682) (Sweat Gland Tubular Carcinoma), [NCIT:C27636](http://purl.obolibrary.org/obo/NCIT_C27636) (Transplant-Related Skin Squamous Cell Carcinoma), [NCIT:C5581](http://purl.obolibrary.org/obo/NCIT_C5581) (Stage I Skin Cancer), [NCIT:C5582](http://purl.obolibrary.org/obo/NCIT_C5582) (Stage II Skin Cancer), [NCIT:C128247](http://purl.obolibrary.org/obo/NCIT_C128247) (Vulvar Merkel Cell Carcinoma), [NCIT:C4819](http://purl.obolibrary.org/obo/NCIT_C4819) (Skin Squamous Cell Carcinoma), [NCIT:C54664](http://purl.obolibrary.org/obo/NCIT_C54664) (Hidradenocarcinoma), [NCIT:C54665](http://purl.obolibrary.org/obo/NCIT_C54665) (Skin Keratotic Basal Cell Carcinoma), [NCIT:C2921](http://purl.obolibrary.org/obo/NCIT_C2921) (Skin Basal Cell Carcinoma), [NCIT:C4027](http://purl.obolibrary.org/obo/NCIT_C4027) (Paget Disease of the Vulva), [NCIT:C4666](http://purl.obolibrary.org/obo/NCIT_C4666) (Spindle Cell (Sarcomatoid) Squamous Cell Skin Carcinoma), [NCIT:C5117](http://purl.obolibrary.org/obo/NCIT_C5117) (Spiradenocarcinoma), [NCIT:C39961](http://purl.obolibrary.org/obo/NCIT_C39961) (Penile Basal Cell Carcinoma), [NCIT:C40310](http://purl.obolibrary.org/obo/NCIT_C40310) (Sebaceous Carcinoma), [NCIT:C38110](http://purl.obolibrary.org/obo/NCIT_C38110) (Skin Signet Ring Cell Basal Cell Carcinoma), [NCIT:C38111](http://purl.obolibrary.org/obo/NCIT_C38111) (Skin Sarcomatoid Basal Cell Carcinoma), [NCIT:C62282](http://purl.obolibrary.org/obo/NCIT_C62282) (Skin Nodular Basal Cell Carcinoma), [NCIT:C2922](http://purl.obolibrary.org/obo/NCIT_C2922) (Skin Basosquamous Cell Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.66%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40066](http://purl.obolibrary.org/obo/NCIT_C40066) (Undifferentiated Ovarian Sarcoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40063](http://purl.obolibrary.org/obo/NCIT_C40063) (Ovarian Low Grade Endometrioid Stromal Sarcoma))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation))) 39.90%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40043](http://purl.obolibrary.org/obo/NCIT_C40043) (Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei))) 39.90%


